Integrated care and optimal management of pulmonary arterial hypertension.

J Multidiscip Healthc

Epidemiology and Preventative Medicine, Monash University, VIC, Australia;

Published: May 2009

Pulmonary arterial hypertension (PAH) may occur as an idiopathic process or as a component of a variety of diseases, including connective tissue diseases, congenital heart disease, and exposure to appetite suppressants or infectious agents such as HIV. Untreated, it is a potentially devastating disease; however, diagnosis can be difficult due to the non-specific nature of symptoms during the early stages, and the fact that patients often present to a range of different medical specialties. The past decade has seen remarkable improvements in our understanding of the pathology associated with the condition and the development of PAH-specific therapies with the ability to alter the natural history of the disease. This article reviews the evidence for screening and diagnosis of susceptible patient groups and discusses treatment selection and recommendations based on data available from randomized controlled trials. In addition, due to the complexity of the diagnostic evaluation required and the treatment options available, this review mandates for a multidisciplinary approach to the management of PAH. We discuss the roles and organizational structure of a specialized PAH center in Perth, Western Australia to highlight these issues.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004560PMC
http://dx.doi.org/10.2147/jmdh.s3085DOI Listing

Publication Analysis

Top Keywords

pulmonary arterial
8
arterial hypertension
8
integrated care
4
care optimal
4
optimal management
4
management pulmonary
4
hypertension pulmonary
4
hypertension pah
4
pah occur
4
occur idiopathic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!